Literature DB >> 21345592

Effects of doxycycline on early infections of Dirofilaria immitis in dogs.

J W McCall1, L Kramer, C Genchi, J Guerrero, M T Dzimianski, P Supakorndej, A Mansour, S D McCall, N Supakorndej, G Grandi, B Carson.   

Abstract

The antifilarial effects of tetracycline drugs were first demonstrated when they were found to be highly effective against L(3) and L(4) of Brugia pahangi and Litomosoides sigmodontis in rodent models. Tetracyclines are also now known to have activity against microfilariae and adult Dirofilaria immitis, but assessment of their activity against larval and juvenile heartworms has not been reported previously. This study assessed the effects of doxycycline administered orally at 10mg/kg twice daily for 30-day periods at selected times during the early part of the life cycle of D. immitis in dogs with dual infections of D. immitis and B. pahangi. Twenty beagles were randomly allocated by weight to four groups of five dogs each. On Day 0, each dog was given 50 D. immitis L(3) and 200 B. pahangi L(3) by SC injection. Dogs received doxycycline on Days 0-29 (Group 1); Days 40-69 (Group 2); or Days 65-94 (Group 3). Group 4 served as untreated controls. Blood samples were collected for microfilariae counting and antigen testing. Necropsy for collection of adult heartworms and selected tissues were performed Days 218-222. Heartworms recovered were examined by immunohistology, conventional microscopy/transmission electron microscopy, and molecular biology techniques. No live heartworms were recovered from dogs in Group 1; dogs in Group 2 had 0 to 2 live worms (98.4% efficacy), and dogs in Group 3 had 0-36 live worms (69.6% efficacy). All control dogs had live adult heartworms (25-41). The live worms recovered from dogs in Groups 2 and 3 were less developed and smaller that worms from control dogs. Microfilariae were not detected in any dogs in Groups 1 and 2; one dog in Group 3 had 1 microfilariae/ml at necropsy. All control dogs had microfilariae at necropsy. One dog in Group 1 was antigen positive at one sampling (Day 166). One dog in Group 2 was antigen positive Days 196 and 218-222 and three dogs in Group 3 were antigen positive at one or more samplings All five control dogs were antigen positive at all three sampling times. These findings suggest that doxycycline at 10mg/kg orally twice daily for 30 days has efficacy against migrating tissue-phase larvae and juvenile worms and will delay or restrict microfilarial production.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21345592     DOI: 10.1016/j.vetpar.2011.01.022

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  5 in total

Review 1.  Heartworm disease - Overview, intervention, and industry perspective.

Authors:  Sandra Noack; John Harrington; Douglas S Carithers; Ronald Kaminsky; Paul M Selzer
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2021-04-27       Impact factor: 4.077

2.  A novel bacterial symbiont in the nematode Spirocerca lupi.

Authors:  Yuval Gottlieb; Eran Lavy; Meira Kaufman; Alex Markovics; Murad Ghanim; Itamar Aroch
Journal:  BMC Microbiol       Date:  2012-07-05       Impact factor: 3.605

3.  Considerations for using minocycline vs doxycycline for treatment of canine heartworm disease.

Authors:  Mark G Papich
Journal:  Parasit Vectors       Date:  2017-11-09       Impact factor: 3.876

4.  Metabolic Abnormalities Detected in Phase II Evaluation of Doxycycline in Dogs with Multicentric B-Cell Lymphoma.

Authors:  Kelly R Hume; Skylar R Sylvester; Lucia Borlle; Cheryl E Balkman; Angela L McCleary-Wheeler; Mary Pulvino; Carla Casulo; Jiyong Zhao
Journal:  Front Vet Sci       Date:  2018-02-26

5.  Molecular Detection and Phylogenetic Analysis of Endosymbiont Wolbachia pipientis (Rickettsiales: Anaplasmataceae) Isolated from Dirofilaria immitis in Northwest of Iran.

Authors:  Majid Khanmohammadi; Reza Falak; Ahmad Reza Meamar; Mehdi Arshadi; Lame Akhlaghi; Elham Razmjou
Journal:  J Arthropod Borne Dis       Date:  2019-03-30       Impact factor: 1.198

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.